The national trend of increased government oversight of opioids continues. As New Hampshire’s legislature fine-tunes new labeling regulations while the U.S. Food and Drug Administration introduces changes to current opioid label requirements. On May 23, the New Hampshire House and Senate each passed separate but related bills that would require orange warning stickers on […]